6Kim SC, Yoon H J, Lee JW, et al. Investigation of the release behavior of DEHP from infusion sets by paclitaxelloaded polymeric micelles[J]. Int J Pharm, 2005, 293(1-2): 303-310.
7Sautou-Miranda V, Brigas F, Vanheerswynghels S, et al. Compatibility of paclitaxel in 5% glucose solution with ECOFLAC low-density polyethylene containers-stability under different storage conditions[J]. Int J Pharm, 1999,178 (1):77-82.
5Ychou M, Duffour J, Kramar A, et al. Individual 5-FU dose adaptation in metastatic colorec cancer:results of a phase Ⅱ study using a bimonthly pharmacokinetically intensified LV5FU2 regime[J] . Cancer Chemother Pharmacol, 2003,52(4):282-290.
6Lombardi D, Di L V, Piani B, et al. Acceptance of exter-nal infusion pumps in patients with advanced breast cancer receiving continuous infusion fluorouracil [J] . Tumori, 2003,89(5):488-491.
7Lawrence T S,Blackstock A W,Ncginn C.The mechanism of action of radiosensitization of conventional chemothera-peutic agents[J].Semin Radiat Oncol,2003,13(1):13-21.
